Skip to main content

Table 3 Selected auxological parameters of the patient during rhGH treatment

From: Recombinant growth hormone therapy in a girl with costello syndrome: a 4-year observation

Age [years and months]

Body height [cm]

Body height SDS

Growth rate [cm/year]

Body weight [kg]

Body weight SDS

BMI [kg/m2]

BMI SDS

Bone age [years and months]

3 years and 2 months

84

−4.94

2.10

10.7

−2.86

15.2

−0.504

 

3 years 9 months (start of rhGH treatment)

84.7

−4.92

0.80

12.1

−2.60

16.9

1.005

3 years

4 years

88.9

−3.48

16.80

12.1

−2.58

15.3

0.02

 

4 years 5 months

92

−3.29

7.44

13.3

−2.41

15.7

0.496

 

4 years 8 months

93.3

−3.31

7.40

14

−2.28

16.1

0.508

4 years 2 months

5 years 2 months

97.8

−2.84

5.20

15.4

−1.80

16.1

0.507

 

5 years 6 months

103

−2.02

9.00

16

−1.77

15.1

0.475

5 years – 5 years 9 months

6 years 1 month

107.5

−1.67

13.00

19

−0.92

16.4

0.511

 

6 years 8 months

109

−1.78

2.57 a

18.4

−1.46

15.5

0.480

7 years 10 months

7 years 2 months

115

−1.61

12.00

20.3

−1.28

15.3

0.466

 
  1. aInterruptions in rhGH administration caused by orthopedic treatment